Why Co-Diagnostics Stock Soared 25% in September
Co-Diagnostics (NASDAQ: CODX) stock surged 24.7% in September, according to data from S&P Global Market Intelligence. For context, the S&P 500 (including dividends) fell 3.8% last month.
Shares of the healthcare diagnostics company have risen 8.9% this month, through Wednesday, Oct. 7. In 2020, the stock has gained a whopping 1,550%, though it's 52% off its closing all-time high of $30.80, reached on Aug. 3. The broader market has returned 7.4% over this period.
Image source: Getty Images.
Source Fool.com
